EP1765365A4 - Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide - Google Patents

Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide

Info

Publication number: EP1765365A4
Authority: EP; European Patent Office
Prior art keywords: drugs; ofr; polysaccharide; delivery; compositions
Prior art date: 2004-06-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05786102A

Other languages

German (de)

French (fr)

Other versions

EP1765365A2 (en

Inventor

David Platt

Eliezer Zomer

Anatole Klyosov

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pro Pharmaceuticals Inc

Original Assignee

Pro Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-22

Filing date

2005-06-21

Publication date

2008-02-20

2005-06-21 Application filed by Pro Pharmaceuticals Inc filed Critical Pro Pharmaceuticals Inc

2007-03-28 Publication of EP1765365A2 publication Critical patent/EP1765365A2/en

2008-02-20 Publication of EP1765365A4 publication Critical patent/EP1765365A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oncology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP05786102A 2004-06-22 2005-06-21 Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide Withdrawn EP1765365A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US58195804P	2004-06-22	2004-06-22
PCT/US2005/021827 WO2006002106A2 (en)	2004-06-22	2005-06-21	Compositions and methods for the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide

Publications (2)

Publication Number	Publication Date
EP1765365A2 EP1765365A2 (en)	2007-03-28
EP1765365A4 true EP1765365A4 (en)	2008-02-20

Family

ID=35782284

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05786102A Withdrawn EP1765365A4 (en)	2004-06-22	2005-06-21	Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide

Country Status (6)

Country	Link
EP (1)	EP1765365A4 (en)
JP (1)	JP2008503583A (en)
CN (1)	CN101267828A (en)
BR (1)	BRPI0512394A (en)
CA (1)	CA2570570A1 (en)
WO (1)	WO2006002106A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2303311B1 (en)	2008-05-14	2018-08-01	Agriculture Victoria Services Pty Ltd	Angiogenin for use in treating skeletal muscle disorders
AU2013204721B2 (en) *	2008-05-14	2016-08-18	Agriculture Victoria Services Pty Ltd	Methods for treating cachexia
CZ302789B6 (en)	2009-11-25	2011-11-09	Zentiva, K. S.	Method of increasing solubility of pharmaceutically active compounds and targeted (controlled) transport thereof into intestine
AU2013204740C1 (en) *	2012-05-10	2015-10-01	Agriculture Victoria Services Pty Ltd	Methods of treating cancer using angiogenin or an angiogenin agonist
FR3022462B1 (en) *	2014-06-18	2018-04-27	Laboratoire Francais Du Fractionnement Et Des Biotechnologies	ORAL COMPOSITION OF ANTI-TNFALPHA ANTIBODY

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5773425A (en) *	1982-05-07	1998-06-30	Carrington Laboratories, Inc.	Antineoplastic uses of aloe products
US5811410A (en) *	1989-09-21	1998-09-22	Hyal Pharmaceutical Corporation	Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
EP0958825A1 (en) *	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
WO2001017377A1 (en) *	1999-09-06	2001-03-15	Beisel Guenther	Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
WO2002076474A1 (en) *	2001-03-27	2002-10-03	Pro-Pharmaceuticals, Inc.	Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
KR20040045795A (en) *	2002-11-25	2004-06-02	주식회사한국신약	Anti-cancer agent comprising polysaccharide obtained from mycelia of Phellinus linteus and mitomycine C

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020107222A1 (en) *	1993-03-01	2002-08-08	David Platt	Modified polysaccharides for treatment of cancer
US5834442A (en) *	1994-07-07	1998-11-10	Barbara Ann Karmanos Cancer Institute	Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin

2005
- 2005-06-21 CA CA002570570A patent/CA2570570A1/en not_active Abandoned
- 2005-06-21 BR BRPI0512394-1A patent/BRPI0512394A/en not_active IP Right Cessation
- 2005-06-21 JP JP2007518186A patent/JP2008503583A/en active Pending
- 2005-06-21 WO PCT/US2005/021827 patent/WO2006002106A2/en not_active Application Discontinuation
- 2005-06-21 EP EP05786102A patent/EP1765365A4/en not_active Withdrawn
- 2005-06-21 CN CNA2005800207078A patent/CN101267828A/en active Pending

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5773425A (en) *	1982-05-07	1998-06-30	Carrington Laboratories, Inc.	Antineoplastic uses of aloe products
US5811410A (en) *	1989-09-21	1998-09-22	Hyal Pharmaceutical Corporation	Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
EP0958825A1 (en) *	1998-05-18	1999-11-24	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
WO2001017377A1 (en) *	1999-09-06	2001-03-15	Beisel Guenther	Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said
WO2002076474A1 (en) *	2001-03-27	2002-10-03	Pro-Pharmaceuticals, Inc.	Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
KR20040045795A (en) *	2002-11-25	2004-06-02	주식회사한국신약	Anti-cancer agent comprising polysaccharide obtained from mycelia of Phellinus linteus and mitomycine C

Also Published As

Publication number	Publication date
BRPI0512394A (en)	2008-03-11
CN101267828A (en)	2008-09-17
JP2008503583A (en)	2008-02-07
EP1765365A2 (en)	2007-03-28
WO2006002106A2 (en)	2006-01-05
WO2006002106A3 (en)	2006-10-19
CA2570570A1 (en)	2006-01-05

Publication	Publication Date	Title
EP1909780A4 (en)	2012-03-07	Anti-tubercular drugs: compositions and methods
IL181734A (en)	2015-10-29	Polymorph i of sorafenib tosylate, pharmaceutical compositions comprising it and its use in the manufacture of medicaments
IL203915A (en)	2016-04-21	2-benzylphenyl-6-hydroxymethyl-tetrahydro-2h-pyran-3,4,5-triol derivatives and pharmaceutical compositions comprising the same
IL194699A (en)	2014-07-31	Tetrahydropteridines, compositions comprising them and use thereof in the preparation of medicaments
IL195488A (en)	2017-04-30	Compounds, pharmaceutical compositions comprising the same and uses thereof
IL194707A (en)	2015-10-29	Synergistic anticancer combination of taxanes and 13-deoxyanthracyclines and a pharmaceutical composition comprising the same
IL190292A (en)	2017-01-31	Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them
EP1962906A4 (en)	2009-11-18	Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
IL184065A (en)	2015-09-24	Tetrahydroquinoline analogues, uses thereof in the preparation of medicaments and pharmaceutical compositions comprising same
IL231576A (en)	2015-09-24	Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments
EP1890677A4 (en)	2013-01-30	Pharmaceutical compositions and use thereof
IL181301A0 (en)	2007-07-04	Cyclopamine analogues, pharmaceutical compositions comprising them and uses thereof
EP1857489A4 (en)	2010-06-23	Microparticle and pharmaceutical composition
EP2056835A4 (en)	2013-01-30	Pharmaceutical compositions and uses thereof
IL206952A (en)	2014-09-30	Aminodihydrothiazine derivatives, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments
IL186738A0 (en)	2008-02-09	Pyrizole derivatives and pharmaceutical compositions containing the same
IL187997A0 (en)	2008-03-20	Indane derivatives and pharmaceutical compositions containing the same
IL177073A0 (en)	2006-12-10	Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
IL193164A0 (en)	2009-08-03	Polymeric conjugates of 7-ethyl-10-hydroxycamptothecin and pharmaceutical compositions containing the same
IL197107A0 (en)	2009-11-18	Pharmaceutical compositions including vitamin d and corticosteriod
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
IL193211A (en)	2013-07-31	Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them
IL178067A0 (en)	2006-12-31	Pharmaceutical dosage forms and compositions
IL179296A0 (en)	2007-03-08	Amphiphilic polymer compositions and their use
IL201730A (en)	2015-09-24	Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments

Legal Events

Date	Code	Title	Description
2007-02-23	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-03-28	17P	Request for examination filed	Effective date: 20061215
2007-03-28	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
2007-03-28	AX	Request for extension of the european patent	Extension state: AL BA HR LV MK YU
2007-09-26	DAX	Request for extension of the european patent (deleted)
2008-02-20	A4	Supplementary search report drawn up and despatched	Effective date: 20080123
2008-02-20	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/50 20060101ALI20080117BHEP Ipc: A61K 38/00 20060101ALI20080117BHEP Ipc: A61K 33/24 20060101ALI20080117BHEP Ipc: A61K 33/00 20060101ALI20080117BHEP Ipc: A61P 35/00 20060101ALI20080117BHEP Ipc: A61K 31/513 20060101ALI20080117BHEP Ipc: A61K 31/337 20060101ALI20080117BHEP Ipc: A61K 31/715 20060101AFI20070110BHEP
2009-07-08	17Q	First examination report despatched	Effective date: 20090605
2010-03-05	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2010-04-07	18D	Application deemed to be withdrawn	Effective date: 20090916